- ESMO Clinical Practice Guidelines
- Abstracts, virtual meetings and meeting reports
- Scientific journal access
- Practice Tools
- Handbooks
- Educational books
- Recommendations for a Global Core Curriculum in MO
- Certification and accreditation
- Educational Programs
- ESMO Handbook CME test
- ESMO E-Learning
- ESMO Highlights 2009
- Useful links
ESMO FAMILY SITES
ESMO Clinical Practice Guidelines
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine. Each CPG includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up.
ESMO is pleased to release the latest enhanced and revised set of guidelines designed to help oncologists deliver an appropriate quality of care to their patients.
Editorial
| ESMO Clinical Practice Guidelines: development, implementation and dissemination |
N. Pavlidis, H. Hansen, and R. Stahel | FULL TEXT |
Breast cancer
| Primary breast cancer | S. Aebi, T. Davidson, G. Gruber, M. Castiglione |
FULL TEXT | |
| Locally recurrent or metastatic breast cancer | F. Cardoso, E. Senkus-Konefka, L. Fallowfield, A. Costa, M. Castiglione |
FULL TEXT | |
| BRCA in breast cancer | J. Balmaña , O. Diey, I. Rubino, M. Castiglione |
FULL TEXT |
Gynecologic tumors
| Newly and relapsed epithelial ovarian carcinoma |
N. Colombo, M. Peiretti, G. Parma, M. Lapresa, R. Mancari, S. Carinelli, C. Sessa, M. Castiglione |
FULL TEXT | |
| Non-epithelial ovarian cancer | N. Reed, D. Millan, R. Verheijen, M. Castiglione |
FULL TEXT | |
| Cervical cancer | C. Haie-Meder, P. Morice, M. Castiglione | FULL TEXT | |
| Endometrial carcinoma | G. Plataniotis, M. Castiglione | FULL TEXT |
Gastrointestinal tumors
| Esophageal cancer | M. Stahl, W. Budach, H.-J. Meyer, A. Cervantes | FULL TEXT | |
| Gastric cancer | A. Okines, M. Verheij, W. Allum, D. Cunningham, A. Cervantes |
FULL TEXT | |
| Pancreatic cancer | C. Cascinu. M. Falconi, V. Valentini, S. Jelic |
FULL TEXT | |
| Hepatocellular carcinoma | S. Jelic, G. C. Sotiropoulos | FULL TEXT | |
| Biliary cancer | F. Eckel, T. Brunner, S. Jelic | FULL TEXT | |
| Primary colon cancer | R. Labianca, B. Nordlinger, G. D. Beretta, A. Brouquet, A. Cervantes |
FULL TEXT | |
| Familial colorectal cancer risk | J. Balmaña, A. Castella, A. Cervantes | FULL TEXT | |
| Rectal cancer | B. Glimelius, L. Påhlman, A. Cervantes | FULL TEXT | |
| Anal cancer | R. Glynne-Jones, J. M. A. Northover, A. Cervantes | FULL TEXT | |
| Advanced colorectal cancer | E. Van Cutsem, B. Nordliner, A. Cervantes | FULL TEXT | |
| Gastrointestinal stromal tumours | P. G. Casali, J.-Y- Blay | FULL TEXT |
Lung cancer
| Early-stage and locally advanced (non-metastatic) non small cell lung cancer |
L. Crinò, W. Weder, J. van Meerbeeck, E. Felip |
FULL TEXT | |
| Metastatic non small cell lung cancer | G. D’Addario, M. Früh, M. Reck, P. Baumann, W. Klepetko, E. Felip |
FULL TEXT | |
| Small-cell lung cancer | M. Sørensen, M. Pijls-Johannesma. E. Felip | FULL TEXT | |
| Malignant pleural mesothelioma | R. A. Stahel, W. Weder, Y. Lievens, E. Felip | FULL TEXT |
Urogenital tumors
| Prostate cancer | A. Horwich, C. Parker, C. Bangma, V. Kataja | FULL TEXT | |
| Bladder cancer | J. Bellmunt, A. Orsola, X. Maldonado, V. Kataja | FULL TEXT | |
| Renal cell cancer | B. Escudier, V. Kataja | FULL TEXT | |
| Testicular seminoma | H.-J. Schmoll, K. Jordan, R. Huddart, M. P. Laguna, A. Horwich, K. Fizazi and V. Kataja |
FULL TEXT | |
| Testicular non-seminoma | H.-J. Schmoll, K. Jordan, R. Huddart, M. P. Laguna, A. Horwich, K. Fizazi and V. Kataja |
FULL TEXT |
Hematologic malignancies
| Multiple myeloma | J.-L. Harousseau and M. Dreyling | FULL TEXT | |
| Acute myeloblastic leukemia in adult patients |
M. Fey and M. Dreyling | FULL TEXT | |
| Chronic lymphocytic leukemia | B. Eichhorst, M. Hallek and M. Dreyling | FULL TEXT | |
| Chronic myeloid leukemia | M. Baccarani and M. Dreyling | FULL TEXT | |
| Hodgkin's lymphoma | A. Engert, D. A. Eichenauer and M. Dreyling | FULL TEXT | |
| Diffuse large B-cell non-Hodgkin's lymphoma |
H. Tilly and M. Dreyling | FULL TEXT | |
| Gastric marginal zone lymphoma of MALT type |
E. Zucca and M. Dreyling | FULL TEXT | |
| Primary cutaneous lymphoma | R. Willemze and M. Dreyling | FULL TEXT | |
| Newly diagnosed and relapsed follicular lymphoma |
M. Dreyling | FULL TEXT |
Head and neck tumors
| Squamous cell carcinoma of the head and neck |
V. Grégoire, J.-L. Lefebvre, L. Licitra, E. Felip |
FULL TEXT | |
| Nasopharyngeal cancer | A. T. C. Chan, V. Greégroire, J.-L. Lefebvre, L. Licitra, E. Felip |
FULL TEXT |
CNS
| High-grade malignant glioma | R. Stupp,J.-C. Tonn, M. Brada,G. Pentheroudakis | FULL TEXT |
Sarcomas and melanomas
| Melanoma | R. Dummer, A. Hauschild, M. Guggenheim, L. Jost, G. Pentheroudakis |
FULL TEXT | |
| Soft tissue sarcomas | P.G. Casali, J.-Y. Blay | FULL TEXT | |
| Bone sarcomas | P.C.W. Hogendoorn | FULL TEXT |
Neuroendocrine tumors
| Thyroid cancer | F. Pacini, M. G. Castagna, L. Brilli and G. Pentheroudakis |
FULL TEXT | |
| Neuroendocrine bronchial and thymic tumors |
K. Öberg, P. Hellman, D. Kwekkeboom, S. Jelic |
FULL TEXT | |
| Neuroendocrine gastroenteropancreatic tumors |
K. Öberg, G. Åkerström, G. Rindi, S. Jelic |
FULL TEXT | |
| Cancers of unknown primary site | N. Pavlidis, E. Briasoulis, G. Pentheroudakis | FULL TEXT |
Supportive care
| Guideline update for MASCC & ESMO in the prevention of chemotherapy and radiotherapy-induced nausea and vomiting |
F. Roila, J. Herrstedt, M. Aapro, R. J. Gralla, L.H. Einhorn, E. Ballatori, E. Bria, R.A. Clark-Snow, B. T. Espersen, P. Feyer, S.M. Grunberg, P.J. Hesketh, K. Jordan, M.G. Kris, E. Maranzano, A. Molassiotis, G. Morrow, I. Olver, B.L. Rapoport, C. Rittenberg, M. Saito, M. Tonato, D. Warr |
FULL TEXT | |
| Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients |
D. Schrijvers, H. De Samblanx, F. Roila | FULL TEXT | |
| Hematopoietic growth factors | J. Crawford, C. Caserta, F. Roila | FULL TEXT | |
| Management of febrile neutropenia | J. de Naurois, I. Novitzky-Basso, M. J. Gill, F. Marti Marti, M. H. Cullen, F. Roila |
FULL TEXT | |
| Management of cancer pain | L. Jost and F. Roila | FULL TEXT | |
| Management of oral and gastrointestinal mucositis |
D. E. Peterson, R.-J. Bensadoun and F. Roila |
FULL TEXT | |
| Cancer, fertility and pregnancy | G. Pentheroudakis, R. Orecchia, H. J. Hoekstra, N. Pavlidis |
FULL TEXT | |
| Venous thromboembolism in cancer patients |
M. Mandalà, A. Falanga and F. Roila |
FULL TEXT | |
| Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease |
D. Bovelli, G. Plataniotis, F. Roila | FULL TEXT |
Acknowledgements
The ESMO Guidelines Working Group acknowledges and thanks the people who have acted as reviewers for these ESMO Clinical Practice Guidelines
Guidelines Working Group Members
Disclosures
The members of the Guidelines Working Group have made the following disclosures
Clinical Practice Guidelines are not designed to replace extensive clinical practice guidelines or review articles, but rather to describe common standards of care.
The ESMO CPG are updated annually by the ESMO Guidelines Working Group, who manages and supervises them, while the ESMO Faculty members perform reviews and provide further expert opinion.
Clinical guidelines are important for the development of oncology as a specialty and serve to achieve many important goals:
- reach and maintain a high common standard of care in medical practice for cancer patients and help clinicians to offer the best care
- disseminate knowledge by supporting the translation into many languages
- support negotiations with politicians, administrators and insurance companies regarding what level of care should be made available
- help patients to find information on the therapies they are undergoing


BACK TO TOP
PRINT THIS PAGE